Variables associated with progression of moderate-to-severe Crohn's disease

被引:4
作者
Beda Sacramento, Carolina da Silva [1 ]
Motta, Marina Pamponet [1 ]
Alves, Candida de Oliveira [1 ]
Mota, Jaciane Araujo [2 ]
Codes, Lina Maria Goes de [3 ]
Ferreira, Reginaldo Freitas [4 ]
Silva, Pedro de Almeida [4 ]
Palmiro, Larissa do Prado [4 ]
Barbosa, Rafael Miranda [4 ]
Andrade, Mariana Nery [5 ]
Andrade, Vitor Damasceno [6 ]
Vasconcelos, Vitor Brandao [5 ]
Thiara, Bernardo Wasconcellos [6 ]
Netto, Eduardo Martins [7 ]
Santana, Genoile Oliveira [8 ]
机构
[1] Hosp Univ Prof Edgard Santos, Dept Gastroenterol, Salvador, Brazil
[2] Hosp Geral Roberto Santos, Dept Gastroenterol, Salvador, Brazil
[3] Hosp Univ Prof Edgard Santos, Dept Proctol, Salvador, Brazil
[4] Univ Estado Bahia, Salvador, Brazil
[5] Escola Bahiana Med & Saude Publ, Salvador, Brazil
[6] Univ Salvador, Salvador, Brazil
[7] Univ Fed Bahia, Salvador, Brazil
[8] Univ Estado Bahia, Ciencias Vida, Salvador, Brazil
来源
BMJ OPEN GASTROENTEROLOGY | 2022年 / 9卷 / 01期
关键词
CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; SURGERY FOR IBD; INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; PREDICTORS; DIAGNOSIS; SURGERY; HOSPITALIZATION; CLASSIFICATION; MANAGEMENT; RECURRENCE; BIOLOGICS;
D O I
10.1136/bmjgast-2022-001016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
ObjectiveDetermine the variables associated with hospitalisations in patients with Crohn's disease and those associated with surgery, intestinal resection, hospital readmission, need for multiple operations and immunobiological agent use.DesignA cross-sectional study was conducted from 2019 to 2021, using two centres for inflammatory bowel diseases in the Brazilian Public Health System.ResultsThis study included 220 patients. Only perianal disease was associated with hospitalisation (31.6% vs 13.0%, p=0.012). Stricturing or penetrating behaviour (35.8% vs 12.6%, p<0.001) and perianal disease (45.9% vs 9.9%, p<0.001) were associated with surgery. Ileal or ileocolonic location (80.0% vs 46.5%, p=0.044) and stricturing or penetrating behaviour (68.0% vs 11.2%, p<0.001) were associated with intestinal resection. Steroids use at first Crohn's disease occurrence and postoperative complications were associated with hospital readmission and need for multiple operations, respectively. Age below 40 years at diagnosis (81.3% vs 62.0%, p=0.004), upper gastrointestinal tract involvement (21.8% vs 10.3%, p=0.040) and perianal disease (35.9% vs 16.3%, p<0.001) were associated with immunobiological agent use.ConclusionPerianal disease and stricturing or penetrating behaviour were associated with more than one significant outcome. Other variables related to Crohn's disease progression were age below 40 years at diagnosis, an ileal or ileocolonic disease localisation, an upper gastrointestinal tract involvement, the use of steroids at the first Crohn's disease occurrence and history of postoperative complications. These findings are similar to those in the countries with a high prevalence of Crohn's disease.
引用
收藏
页数:8
相关论文
共 40 条
  • [1] [Anonymous], Open Source Epidemiologic Statictics for Public Health
  • [2] [Anonymous], 2010, ARQ GASTROENTEROL, V47, P313
  • [3] Risk factors regarding the need for a second operation in patients with Crohn's disease
    Avidan, B
    Sakhnini, E
    Lahat, A
    Lang, A
    Koler, M
    Zmora, O
    Bar-Meir, S
    Chowers, Y
    [J]. DIGESTION, 2005, 72 (04) : 248 - 253
  • [4] Predictors of Crohn's disease
    Beaugerie, L
    Seksik, P
    Nion-Larmurier, I
    Gendre, JP
    Cosnes, J
    [J]. GASTROENTEROLOGY, 2006, 130 (03) : 650 - 656
  • [5] The Role of Early Biologic Therapy in Inflammatory Bowel Disease
    Berg, Dana Rachel
    Colombel, Jean-Frederic
    Ungaro, Ryan
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1896 - 1905
  • [6] The Use of Prognostic Factors in Inflammatory Bowel Diseases
    Billiet T.
    Ferrante M.
    Van Assche G.
    [J]. Current Gastroenterology Reports, 2014, 16 (11) : 1 - 14
  • [7] Burisch J., 2019, INTESTINE, V68, P423
  • [8] Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study
    Chaparro, M.
    Garre, A.
    Nunez Ortiz, A.
    Diz-Lois Palomares, M. T.
    Rodriguez, C.
    Riestra, S.
    Vela, M.
    Benitez, J. M.
    Fernandez Salgado, E.
    Sanchez Rodriguez, E.
    Hernandez, V.
    Ferreiro-Iglesias, R.
    Ponferrada Diaz, A.
    Barrio, J.
    Huguet, J. M.
    Arias, L.
    Martin-Arranz, M. D.
    Calvet, X.
    Ginard, D.
    Alonso-Abreu, I.
    Fernandez-Salazar, L.
    Varela Trastoy, P.
    Rivero, M.
    Vera-Mendoza, I.
    Vega, P.
    Navarro, P.
    Sierra, M.
    Cabriada, J. L.
    Aguas, M.
    Vicente, R.
    Navarro-Llavat, M.
    Echarri, A.
    Gomollon, F.
    Guerra del Rio, E.
    Casanova, M. J.
    Spicakova, K.
    Ortiz de Zarate, J.
    Alonso-Galan, H.
    Barreiro-de Acosta, M.
    Gisbert, J. P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S018 - S020
  • [9] Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
    Cholapranee, A.
    Hazlewood, G. S.
    Kaplan, G. G.
    Peyrin-Biroulet, L.
    Ananthakrishnan, A. N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) : 1291 - 1302
  • [10] Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study
    da Luz Moreira, Andre
    de Campos Lobato, Luiz Felipe
    de Lima Moreira, Jessica Pronestino
    Luiz, Ronir Raggio
    Elia, Celeste
    Fiocchi, Claudio
    de Souza, Heitor Siffert Pereira
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1696 - 1708